Singapore-headquartered telehealth startup Doctor Anywhere today announced it has secured a $27 million Series B financing round led by Square Peg – the largest venture capital fund in Australia, Singapore Government investment arm – EDBI, and IHH Healthcare, a leading international healthcare provider. Other participants in this round of funding are Pavilion Capital and existing shareholder Kamet Capital, bringing Doctor Anywhere’s total capital base to exceed $40 million.

The telehealth startup will use the funds for its extensive expansion to augment the region’s healthcare landscape through digital transformation, with the support of strong local and regional partners.

Doctor Anywhere also recently launched its platform in Thailand, in partnership with one of Thailand’s most established private hospitals, and a global corporate insurance provider serving more than 95 million customers worldwide. Doctor Anywhere also operates in key cities of Vietnam, namely Hanoi and Ho Chi Minh City, with announcements on other regional plans in the pipeline due later this year.

THE LARGER TREND

Last October, Doctor Anywhere partnered with ViettelPay to provide online healthcare services in Vietnam, MobiHealthNews reported. In September 2019, the startup signed an agreement with Vietnam’s Bao Minh insurance, which will provide the insurer’s more than 7 million customers access to Doctor Anywhere's suite of digital healthcare solutions.

ON THE RECORD

Lim Wai Mun, Founder and CEO, Doctor Anywhere, said: “I am thrilled to announce our partnership with this group of outstanding institutional investors, especially at a time when global healthcare challenges are top-of-mind in many countries.”

“Our mission is to make healthcare cost-effective and accessible for everyone, and I feel grateful that our partners share the same vision of transforming the traditionally conservative healthcare industry. With our partners' significant influence and astute industry insights, we are rapidly becoming the leading tech-led health and wellness platform in Asia.”